It is generally recommended that every tubo-ovarian/primary peritoneal high-grade serous carcinoma be tested for at least somatic BRCA1/2 gene mutations, in addition to mutations in other high-risk genes (96). Here, BRCA1 is linked to serous adenocarcinoma.